Cue Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CUE Key Statistics
Stock Snapshot
As of today, Cue Biopharma(CUE) shares are valued at $31.16. The company's market cap stands at 132.39M, with a P/E ratio of -5.64.
During the trading session on 2026-07-18, Cue Biopharma(CUE) shares reached a daily high of $31.52 and a low of $25.50. At a current price of $31.16, the stock is +22.2% higher than the low and still -1.1% under the high.
Trading activity shows a volume of 122.5K, compared to an average daily volume of 165.19K.
The stock's 52-week range extends from a low of $4.97 to a high of $45.50.
The stock's 52-week range extends from a low of $4.97 to a high of $45.50.
CUE News
Cue Biopharma (CUE) announced the appointment of Dominic Borie as chief medical officer, and head of research and development. He reports to president and CEO S...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.